Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
32 participants
INTERVENTIONAL
2008-07-31
2014-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Cleaning the bowel without complications for the patient is one of the aims for this study.
The other aim is to see if patient nutritional status improves with nutritional drinks as a complement to food intake 4-6 weeks before surgery.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Does Icodextrin Reduce the Risk of Small Bowel Obstruction?
NCT02318888
Molecular Determinants of Response to Preoperative Therapy in Patients With Locally Advanced Colorectal Cancer
NCT02877056
Bowel Dysfunction After Low Rectal Resection. An Pilot Study Using Psyllium Husk In Rectal Cancer Patients.
NCT06724198
Inflammation After Laparoscopic Robot-assisted Surgery for Locally Advanced Rectal Cancer
NCT04324567
Endoscopic Submucosal Injection of Indocyanine Green Before Laparoscopic Radical Resection for Colorectal Cancer
NCT04207489
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The actual study's purpose is to find out if rectal cancer surgery can be performed without traditionally bowel preparation. Nutritional drinks are to be used instead of traditional bowel preparation. Patients are randomized into two groups, stratification for stricture, malnutrition and laparoscopic surgery and each group should either bee treated with traditional bowel preparation, Laxabon® (A) or nutritional drinks, Fresubin Energy drink (B) before surgery. Patients in subgroup B take nutritional drinks seven days before surgery instead of ordinary food. Bowel purity degree is measured peroperatively.
The secondary aim is to see if malnutrition can be improved with nutritional drinks as a complement to ordinary food intake before surgery. For four to six weeks before surgery 50 % or more of the caloric need is substituted with nutritional drinks in subgroup B (Fresubin Energy drink 15-30 kcal/kg\*day). Subgroup A only eats ordinary food throughout the same period, before surgery.
Bowel purity degree, physiological functions, and body mass index are measured in all four groups before and after surgery. All patients in the study keep records of physical activity daily, and food diary twice a week. Complications are registered.
Blood samples for hormones and electrolytes are taken before and after surgery.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
B
Nutritional drinks 7 days before surgery instead of traditional Bowel preparation with Laxabon®
Fresubin Energy Drink
Fresubin energy drink 30 kcal/kg\*dag-1, seven days before surgery
A
Traditional bowel preparation with Laxabon®
Laxabon®
Laxabon® 4 litres starting the day before surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fresubin Energy Drink
Fresubin energy drink 30 kcal/kg\*dag-1, seven days before surgery
Laxabon®
Laxabon® 4 litres starting the day before surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* men
* women
* age 18-90 years
Exclusion Criteria
* seriously dementia
* metastatic disease
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Karolinska Institutet
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ulf Gustafsson
PhD, MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ulf Gustafsson, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Karolinska Institut
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Department, Ersta Hospital
Stockholm, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2008/332-31
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.